BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 18679537)

  • 1. Perispinal etanercept produces rapid improvement in primary progressive aphasia: identification of a novel, rapidly reversible TNF-mediated pathophysiologic mechanism.
    Tobinick E
    Medscape J Med; 2008 Jun; 10(6):135. PubMed ID: 18679537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid improvement in verbal fluency and aphasia following perispinal etanercept in Alzheimer's disease.
    Tobinick EL; Gross H
    BMC Neurol; 2008 Jul; 8():27. PubMed ID: 18644112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deciphering the physiology underlying the rapid clinical effects of perispinal etanercept in Alzheimer's disease.
    Tobinick E
    Curr Alzheimer Res; 2012 Jan; 9(1):99-109. PubMed ID: 22191562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration.
    Tobinick EL; Gross H
    J Neuroinflammation; 2008 Jan; 5():2. PubMed ID: 18184433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perispinal etanercept for treatment of Alzheimer's disease.
    Tobinick E
    Curr Alzheimer Res; 2007 Dec; 4(5):550-2. PubMed ID: 18220520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour necrosis factor modulation for treatment of Alzheimer's disease: rationale and current evidence.
    Tobinick E
    CNS Drugs; 2009 Sep; 23(9):713-25. PubMed ID: 19689163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid improvement of chronic stroke deficits after perispinal etanercept: three consecutive cases.
    Tobinick E
    CNS Drugs; 2011 Feb; 25(2):145-55. PubMed ID: 21254790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective TNF inhibition for chronic stroke and traumatic brain injury: an observational study involving 629 consecutive patients treated with perispinal etanercept.
    Tobinick E; Kim NM; Reyzin G; Rodriguez-Romanacce H; DePuy V
    CNS Drugs; 2012 Dec; 26(12):1051-70. PubMed ID: 23100196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid improvement in severe long COVID following perispinal etanercept.
    Tobinick E; Spengler RN; Ignatowski TA; Wassel M; Laborde S
    Curr Med Res Opin; 2022 Dec; 38(12):2013-2020. PubMed ID: 35791687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perispinal etanercept: potential as an Alzheimer therapeutic.
    Griffin WS
    J Neuroinflammation; 2008 Jan; 5():3. PubMed ID: 18186919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perispinal etanercept for neuroinflammatory disorders.
    Tobinick E
    Drug Discov Today; 2009 Feb; 14(3-4):168-77. PubMed ID: 19027875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perispinal etanercept: a new therapeutic paradigm in neurology.
    Tobinick E
    Expert Rev Neurother; 2010 Jun; 10(6):985-1002. PubMed ID: 20518613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immediate neurological recovery following perispinal etanercept years after brain injury.
    Tobinick E; Rodriguez-Romanacce H; Levine A; Ignatowski TA; Spengler RN
    Clin Drug Investig; 2014 May; 34(5):361-6. PubMed ID: 24647830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perispinal TNF-alpha inhibition for discogenic pain.
    Tobinick EL; Britschgi-Davoodifar S
    Swiss Med Wkly; 2003 Mar; 133(11-12):170-7. PubMed ID: 12715286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perispinal etanercept for post-stroke neurological and cognitive dysfunction: scientific rationale and current evidence.
    Ignatowski TA; Spengler RN; Dhandapani KM; Folkersma H; Butterworth RF; Tobinick E
    CNS Drugs; 2014 Aug; 28(8):679-97. PubMed ID: 24861337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of etanercept delivered by perispinal administration for chronic back and/or neck disc-related pain: a study of clinical observations in 143 patients.
    Tobinick E; Davoodifar S
    Curr Med Res Opin; 2004 Jul; 20(7):1075-85. PubMed ID: 15265252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central delivery of iodine-125-labeled cetuximab, etanercept and anakinra after perispinal injection in rats: possible implications for treating Alzheimer's disease.
    Roerink ME; Groen RJ; Franssen G; Lemmers-van de Weem B; Boerman OC; van der Meer JW
    Alzheimers Res Ther; 2015 Nov; 7(1):70. PubMed ID: 26560086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of post-anesthesia dementia with perispinal etanercept injection and hyperbaric oxygen therapy: a case report.
    Best S; Pavel DG
    J Med Case Rep; 2017 Apr; 11(1):105. PubMed ID: 28407792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary progressive aphasia: clinicopathological correlations.
    Grossman M
    Nat Rev Neurol; 2010 Feb; 6(2):88-97. PubMed ID: 20139998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary progressive aphasia: a review of the neurobiology of a common presentation of Pick complex.
    Kertesz A; Munoz DG
    Am J Alzheimers Dis Other Demen; 2002; 17(1):30-6. PubMed ID: 11831418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.